News

  • New Publication: A Randomized Trial of Nafamostat for Covid-19

    by ASCOT Trial
    Image: 2020 The University of Tokyo. We are once again delighted to announce the ASCOT Trial publication in NEJM Evidence, this time for the antivi...

  • New Publication: Anticoagulation Strategies for Non-Critically Ill Patients with COVID-19

    by ASCOT Trial
    We are delighted to announce that the results from the Anticoagulation Domain have now been published in NEJM Evidence and presented by ASCOT CI Zo...

  • ASCOT and REMAP-CAP awarded nearly $4 million to combine platforms to test new therapeutics to treat COVID-19

    by ASCOT Trial
    ASCOT and REMAP-CAP have been awarded $3,997,914 by the Australian Government through the Medical Research Future Fund (MRFF) in a joint proposal t...

  • ASCOT closes the Antiviral Treatment Domain

    by ASCOT Trial
    On Thursday, 11 August 2022, the ASCOT Trial Steering Committee (TSC), with support from the Antiviral Domain-Specific Working Group (DSWG), made t...

  • ASCOT closes the Anticoagulation Treatment Domain

    by Doherty Media
    On Thursday, 7 April 2022, the ASCOT Trial Steering Committee (TSC), with support from the Anticoagulation Domain-Specific Working Group (DSWG), ma...

  • COVID-19 clinical trials disproportionately run out of high-income countries research shows

    by Doherty Media
    New research has shown that COVID-19 clinical trials are being disproportionately run out of high-income countries.

  • ASCOT randomises 1,000th patient

    by ASCOT Trial
    Australasian COVID-19 Trial (ASCOT) reached an important milestone on Tuesday, 21 September 2021, randomising the 1,000th patient into the study. T...

  • ASCOT removes aspirin from trial

    by ASCOT Trial
    On the 22 July 2021, the ASCOT International Trial Steering Committee (ITSC) made the decision to cease patient enrolment into aspirin-containing a...

  • Oxford is trialling Ivermectin - the path to this point has been rocky, why?

    by Doherty Media
    By Associate Professor Justin Denholm, Principal Investigator on ASCOT The PRINCIPLE trial recently announced that their ongoing platform will now ...

  • COVID-19 – The Israel experience

    by Doherty Media
    By Dr Neta Petersiel, Clinical Research Fellow for ASCOT  The past 18 months often feel like a weird dream, our reality perhaps forever changed by ...

  • National approach to pandemic research needed

    by Doherty Media
    Australia should follow the examples of the UK and parts of the US and establish a national, coordinated approach for randomised controlled trials...

  • Infection and Immunity – Evidence Explained podcast: COVID-19 treatments part one, the Australian experience

    by Doherty Media
    In the latest episode of Doherty Institute's Infection and Immunity - Evidence Explained podcast, Associate Professor Steven Tong, Infectious Disea...